Eli Lilly is launching LillyDirect to deliver Mounjaro straight to Australian patients’ doors — and local doctors and ...
Ahead of this year's Nobel Prize announcements, STAT chatted with Mary-Claire King, who discovered the BRCA cancer mutations ...
Congo's Ebola outbreak has killed more than 4,000 people, authorities said, as they struggle to contain what has become the ...
WASHINGTON — The Make America Healthy Again movement wants your health data. The MAHA Institute, a think tank formed by allies of Robert F. Kennedy Jr. after his appointment as health secretary, held ...
The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.
News of a fifth measles death in Pennsylvania underscores a longstanding issue about the disease. The full scope of the ...
Lizzy led STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.
DHS has appealed a court ruling blocking it from restricting how long international students and postdoctoral researchers can ...
The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of ...
Premiums are stable, but Medicare Advantage plans are making big changes that could make care more expensive for patients.
Proposed changes to the federal government’s health survey would undercount Americans with disabilities, advocates say.
Sanofi and Regeneron have re-upped their collaboration pact, aiming to build on the blockbuster success of the drug Dupixent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results